Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of NKT-01 in refractory Wegener's granulomatosis
jRCT2080220107Phase 2
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of deoxyspergualin in granulomatosis with polyangiitis (GPA), sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
deoxyspergualin
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on jRCT2080220107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220107.